Skip to content
10-K

Annual Report

ProMIS Neurosciences Inc. PMN

0001104659-26-034554

← back to feed
Filed
Mar 25, 2026 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Mar 25, 2026 8.97M sh
Shares Diluted FY 2025 · Dec 31, 2025 1.76M sh
Shares Diluted restated FY 2025 · Dec 31, 2024 1.06M sh
Operating Cash Flow FY 2025 · Dec 31, 2025 −$28.12M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$27.18M
Short Term Investments FY 2025 · Dec 31, 2025 $33.75K
Short Term Investments FY 2025 · Dec 31, 2024 $33.05K
Cash And Equivalents FY 2025 · Dec 31, 2025 $6.12M
Cash And Equivalents FY 2025 · Dec 31, 2024 $13.29M
Stockholders Equity FY 2025 · Dec 31, 2025 −$1.26M
Stockholders Equity FY 2025 · Dec 31, 2024 $16.49M
Stockholders Equity FY 2025 · Dec 31, 2023 $3.75M
Current Liabilities FY 2025 · Dec 31, 2025 $10.41M
Current Liabilities FY 2025 · Dec 31, 2024 $2.22M
Total Liabilities FY 2025 · Dec 31, 2025 $10.44M
Total Liabilities FY 2025 · Dec 31, 2024 $2.42M
Current Assets FY 2025 · Dec 31, 2025 $9.18M
Current Assets FY 2025 · Dec 31, 2024 $18.91M
Total Assets FY 2025 · Dec 31, 2025 $9.18M
Total Assets FY 2025 · Dec 31, 2024 $18.91M
Eps Diluted FY 2025 · Dec 31, 2025 −$22.61
Eps Diluted restated FY 2025 · Dec 31, 2024 $2.63
Eps Basic FY 2025 · Dec 31, 2025 −$22.61
Eps Basic restated FY 2025 · Dec 31, 2024 $2.68
Sga Expense FY 2025 · Dec 31, 2025 $6.79M
Sga Expense FY 2025 · Dec 31, 2024 $6.19M
Rd Expense FY 2025 · Dec 31, 2025 $33.38M
Rd Expense FY 2025 · Dec 31, 2024 $10.64M
Net Income FY 2025 · Dec 31, 2025 −$39.72M
Net Income FY 2025 · Dec 31, 2024 $2.78M
Operating Income FY 2025 · Dec 31, 2025 −$40.17M
Operating Income FY 2025 · Dec 31, 2024 −$16.83M